Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia 12Breast Neoplasms 11Leukemia, Myeloid, Acute 9Congenital Abnormalities 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myeloproliferative Disorders 7Multiple Myeloma 7Lymphoma, Mantle-Cell 7Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Waldenstrom Macroglobulinemia 5Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Colorectal Neoplasms 5Colonic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Burkitt Lymphoma 5Squamous Cell Carcinoma of Head and Neck 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma 4Lung Neoplasms 4Leukemia, Myeloid, Accelerated Phase 4Head and Neck Neoplasms 4Central Nervous System Neoplasms 4Blast Crisis 4Sezary Syndrome 3

Interventions

zenocutuzumab 2seribantumab 2pembrolizumab 1patritumab 1osimertinib 1exemestane 1enzalutamide 1cemiplimab 1Vinorelbine 1Vascular Endothelial Growth Factor A 1Trastuzumab 1Paroxetine 1Paclitaxel 1Letrozole 1Itraconazole 1In Situ Hybridization, Fluorescence 1Fulvestrant 1Erlotinib Hydrochloride 1Docetaxel 1Carboplatin 1Antibodies, Bispecific 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lethal Congenital Contracture Syndrome 2 × In Situ Hybridization, Fluorescence × Clear all
NCT00740532 2010-09-02

Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients

Istituto Clinico Humanitas

Completed
11 enrolled
Breast

Lethal Congenital Contracture Syndrome 2, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡